CDC Advisers Discuss Narrowing Recommendations On Use Of COVID-19 Booster Shots

Reuters (4/15, Sunny, S K) reports the Centers for Disease Control and Prevention on Tuesday convened the first meeting of the Advisory Committee on Immunization Practices under the Trump Administration after a nearly two-month delay. The experts “discussed narrowing recommendations on the use of COVID-19 booster shots for the upcoming immunization campaign” to only “vulnerable populations at risk of severe COVID-19 for the 2025-2026 season.” Meanwhile, the committee will vote Wednesday “on recommendations for use of three vaccines also discussed during the two-day meeting, shots for respiratory syncytial virus, chikungunya, a mosquito-borne disease, and meningococcal vaccines.” They will also “discuss the ongoing U.S. measles outbreak that has infected over 700 people this year.” Bloomberg Law (4/15, Smith, Subscription Publication) notes that the committee “gathers a few times a year to review data and make recommendations that determine when vaccines are given and whether they are covered by insurance. The influential group, mostly unknown outside of public health circles, normally does business with little fanfare.”